0.00Open6.60Pre Close0 Volume0 Open Interest66.00Strike Price0.00Turnover2810.86%IV-7.04%PremiumNov 22, 2024Expiry Date12.10Intrinsic Value100Multiplier-5DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type0.9678Delta0.0186Gamma11.83Leverage Ratio-99.9933Theta0.0000Rho11.45Eff Leverage0.0001Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
Great products sells itself, ask novo disk and how they sell ozempic
No comment yet